Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1549 of 5804
-
New drug combo shows promise for Tough-to-Treat liver cancer
Disease control CompletedThis phase II trial studies the effect of futibatinib and pembrolizumab in treating patients with FGF19 positive BCLC stage A, B, or C liver cancer that has spread to other parts of the body (advanced or metastatic). Futibatinib may stop the growth of cancer cells by blocking som…
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Front vs back surgery: which is better for stiff spine condition?
Disease control OngoingThe purpose of this study is to compare the efficacy, safety and imaging outcomes between Anterior Controllable Antedisplacement and Fusion (ACAF) and Laminoplasty in the treatment of severe ossification of cervical posterior longitudinal ligament.
Phase: NA • Sponsor: Shanghai Changzheng Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Frozen hope: new study offers fertility option for rare condition
Disease control Recruiting nowThe "Gonadal Dysgenesis Tissue Cryopreservation for Fertility Preservation" study is open to a subset of patients with disorders of sex development (DSD) which is associated with the risk of malignancy and a high risk of infertility or sterility. For these patients, experimental …
Phase: NA • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 26, 2026 18:05 UTC
-
Could stem cells mend broken hearts in diabetes?
Disease control CompletedThe purpose of this study is to test the hypothesis that allogeneic Mesenchymal Stem Cells (MSCs) promote systemic and coronary endothelial repair through rescue of bone marrow progenitors in type 2 diabetic patients with symptomatic IHD compared to placebo.
Phase: PHASE1, PHASE2 • Sponsor: Joshua M Hare • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New powder dressing shows promise for healing diabetic foot sores
Disease control CompletedPhase IV, randomized, prospective, multi-center, open-label, comparison of transforming powder dressing to standard of care dressing for healing diabetic foot ulcers.
Phase: NA • Sponsor: ULURU Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New drug safety check for Hard-to-Treat lymphoma patients
Disease control OngoingThe primary purpose of the study is to investigate the safety of tazemetostat in participants with relapsed or refractory follicular lymphoma with EZH2 gene mutation under daily clinical practice.
Sponsor: Eisai Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Sound waves zapping pain: new hope for facial neuralgia?
Symptom relief OngoingThe purpose of this study is to assess the safety and effectiveness of MRI-guided focused ultrasound (MRgFUS) for treating Trigeminal Neuralgia. Trigeminal Neuralgia (pain) is a type of pain involving the face that can be disabling to those it affects.
Phase: NA • Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC
-
Blood test could spare cancer patients from unnecessary side effects
Knowledge-focused Recruiting nowThe FOLICOLOR trial aims to evaluate whether a liquid biopsy-guided follow-up strategy can improve outcomes in patients with unresectable, metastatic colorectal cancer (mCRC) receiving first-line systemic treatment. The approach uses NPY methylation-based circulating tumor DNA (c…
Phase: PHASE3 • Sponsor: University Hospital, Antwerp • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC
-
New study aims to find best way to unblock stomachs in cancer patients
Symptom relief ENROLLING_BY_INVITATIONGastric outlet obstruction (GOO) refers to a mechanical blockage of the distal stomach or duodenum that prevents normal passage of food and liquids. According to literature, 50-80% of GOO cases are caused by malignant tumors compressing or directly invading the gastrointestinal t…
Sponsor: National Taiwan University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
New study explores letrozole's effects on breast cancer before surgery
Disease control OngoingThis is a single-arm, open-label study testing the effects of neoadjuvant therapy with the aromatase inhibitor letrozole in post-menopausal women with Stage I-III ER+, HER2- breast cancer. Eligible subjects will be treated with letrozole therapy for 4 to 24 weeks prior to surgica…
Phase: PHASE2 • Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Experimental drug combo targets Hard-to-Treat GI cancers
Disease control OngoingThis phase I trial investigates the best dose, possible benefits and/or side effects of BAY 1895344 in combination with FOLFIRI in treating patients with stomach or intestinal cancer that that may have spread from where it first started to nearby tissue, lymph nodes, or distant p…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Real-World dupixent study tracks Long-Term relief for sinusitis and nasal polyps
Disease control OngoingThe primary objectives of the study are: * To longitudinally characterize the long-term effectiveness of DUPIXENT® through assessment of patient-reported symptoms, Health-Related Quality of Life (HRQoL) related to Chronic rhinosinusitis with nasal polyposis (CRSwNP) and other ty…
Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Smart radiation aims to zap liver tumors with fewer side effects
Disease control Recruiting nowStereotactic body radiotherapy (SBRT) is an established local treatment method for patients with hepatic oligometastases. Liver metastases often occur in close proximity to radiosensitive organs at risk (OARs). This limits the possibility to apply sufficiently high doses needed f…
Phase: PHASE2 • Sponsor: University Hospital Heidelberg • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New hope for asthma and polyp sufferers? mepolizumab under the microscope
Disease control CompletedPrimary objective: to investigate the efficacy of Mepolizumab 100 milligram (mg) every month compared to placebo in reducing validated Sinonasal Outcome Test -22 score and on reducing endoscopic Nasal Polyp Score. The participants have a triad of chronic rhinosinusitis with nasa…
Phase: PHASE4 • Sponsor: Helsinki University Central Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Can a smartphone app sharpen the mind in early psychosis?
Symptom relief OngoingThe purpose of this study is to perform a practice-based research project designed to assess whether cognition and motivated behavior in early psychosis can be addressed as key treatment goals within real-world settings by using a 12-week mobile intervention program. Participants…
Phase: NA • Sponsor: University of Minnesota • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
New drug cocktail aims to tame rare blood cancers
Disease control Recruiting nowThis study will test the safety of ruxolitinib, given at one dose that does not change, and duvelisib, given at different doses, to find out what effects, if any, the study treatment has on people with relapsed or refractory NK-cell or T-cell lymphoma. This study has three parts…
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Can a common arthritis drug ease hand pain? new study investigates
Disease control OngoingA placebo-controlled randomized controlled trial exploring the effect of methotrexate on pain, function and structural outcomes in erosive inflammatory hand osteoarthritis.
Phase: PHASE4 • Sponsor: Diakonhjemmet Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New hope for kids with rare kidney diseases: drug trial aims to cut protein leak
Disease control Recruiting nowTo evaluate the safety, efficacy and tolerability of sparsentan oral suspension and tablets, and assess changes in proteinuria after once-daily dosing over 108 weeks.
Phase: PHASE2 • Sponsor: Travere Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New study pokes at best fix for leaky heart valve in Blocked-Artery patients
Disease control OngoingIschemic mitral regurgitation (MR) and coronary artery disease is common and associated with significant morbidity and mortality. Ischemic MR has been traditionally treated surgically through either valve repair or replacement at the time of concomitant bypass grafting. Although …
Phase: NA • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Could a common drug slow Alzheimer's? new study tests rapamycin
Disease control OngoingThis study will evaluate the safety, tolerability, and feasibility of 12 month oral rapamycin treatment in older adults with amnestic mild cognitive impairment (aMCI) and early stage Alzheimer's disease (AD).
Phase: PHASE2 • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC